Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Jordan
With
Jordan Hospital
Objective: this study aimed to evaluate clinical pharmacists' role in the management of uncontrolled hypertensive patients in Jordan. Design: single blinded randomized controlled clinical trial. Patients: 253 patients with uncontrolled hypertension specified as higher blood pressure readings than the recommended goals by the seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure (JNC VII) at the time of enrollment.
Interventions: patients were randomly allocated to an intervention or control group: 130 and 123 patients, respectively. Patients in both arms were followed up for 6 months. In the intervention group, patients were managed by physician-clinical pharmacist team. In the control group, patients were managed by physician(s) only and were not provided pharmaceutical care services.
Age
21–88
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with uncontrolled BP, receiving 0-3 antihypertensive drugs with no change in the regimen or dose within the past 3 month.
You may not be if
Patients with hypertensive urgency or emergency with BP more than (180/110).
Patients with recent stroke or myocardial infraction (within past 6 months).
Patients with Class III or IV Chronic heart Failure (CHF).
Patients with Unstable angina.
Patients with Serious renal or hepatic disease.
Pregnant patients.
Patients with Dementia or cognitive impairment.
If the patient is unable to provide informed written consent.